AUG 31, 2016 02:19 PM PDT

Explaining Slow Recovery from Bone Marrow Transplants

WRITTEN BY: Kara Marker
Replacing faulty stem cells in the bone marrow with a transplant is one way to treat some bone cancers, but the immune recovery process following the procedure is often tedious, leaving a person vulnerable to other infections. With the discovery of a molecule involved in this immune recovery, scientists from the University of Birmingham may hold the key to improving recovery following bone marrow transplant surgeries. 
A plot of immature T cells in the thymus: T cell progenitors in red.
A molecule called Lymphotoxin beta receptor was found in a recent Journal of Immunology study to regulate the influx of T cell progenitors into the thymus, a vital lymphoid gland that nurtures T cells into mature lymphocytes to be released into the bloodstream to participate in adaptive immune responses. The role thymus plays in the development of these immune cells is the reason they are called “T” cells.

Both when an individual is healthy and when an individual is experiencing immune recovery, the Lymphotoxin beta receptor is required for T cell entry into the thymus. In theory, the receptor could be inhibiting or reducing the amount of T cells allowed to enter the thymus after a bone marrow transplantation. In the words of Birmingham professor Graham Anderson: “as if the doorway to the thymus is closed.”

In their studies, Birmingham scientists used mouse models to study the role of Lymphotoxin beta receptor in regulating the thymus. “Identifying molecular regulators that can ‘prop open’ the door and allow these cells to enter and mature,” Anderson said, “could well be a means to help reboot the immune system.”

In an effort to manually stimulate the Lymphotoxin beta receptor to allow more T cell progenitors access to the the thymus, researchers used antibody-mediated stimulation in the mice. The stimulation successfully enhanced initial thymus recovery and also “boosted the number of transplant-derived T cells.”

According to the study scientists, cancer patients receiving bone marrow often take years to recover their T cell population. With the right future studies, bone marrow transplant patients could soon be benefiting from drugs that stimulate their Lymphotoxin beta receptors. In fact, the same group from Birmingham will soon start examining in vitro human samples of thymus tissue to further investigate the role of Lymphotoxin beta receptor in human thymus regulation.

More about bone marrow transplants 

Bone marrow tissue contains stem cells that develop into white blood cells, like T cells, red blood cells, and platelets. Bone marrow transplants are done to treat different conditions such as leukemia and other blood cancers, aplastic anemia and other diseases that cause bone marrow failure, and other immune disorders and genetic diseases.
 


Sources: Healthline, MedlinePlus, Be The Match, University of Birmingham
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 19, 2018
Videos
JUL 19, 2018
Hazmat Spill at Johns Hopkins
Biohazards are a common problem in any kind of scientific research, and if a spill of dangerous materials occurs, it can be deadly. Luckily, a recent spill...
JUL 25, 2018
Immunology
JUL 25, 2018
T Cell Response to Ebola Virus Proteins
Killer T cells of Ebola survivors respond better to nucleoproteins, not glycoproteins, potentially influencing Ebola vaccine development....
SEP 03, 2018
Immunology
SEP 03, 2018
Insulin Boosts the Immune System
Insulin boosts T cells to better fight infection and bolster the immune response....
SEP 07, 2018
Health & Medicine
SEP 07, 2018
What's Behind the Massive Measles Outbreak in Europe?
Measles is a disease that many believe was eradicated years ago. That's true, to a point, but like a bad penny, it's back. In the United States, th...
SEP 25, 2018
Videos
SEP 25, 2018
Heal Faster
Active patient vs passive patient...
OCT 14, 2018
Immunology
OCT 14, 2018
The Stem of Cancer
Scientists reveal a pathway involved in cancer cell ability to act as stem cells...
Loading Comments...